MediPharm Labs and Cronos Group Enter Private Label Contract Manufacturing Agreement MediPharm to produce high-quality cannabis concentrate filled vapes for Cronos Group Deal reinforces MediPharm Labs’ leadership in large...
After a 54.9% gain in Q1, the Canadian Cannabis LP Index has done a complete round-trip, with the index extending its losing streak to five months after declining in August by...
The Public Cannabis Company Revenue Tracker, managed by New Cannabis Ventures, ranks the top revenue producing cannabis stocks that generate industry sales of more than US$5.0 million per quarter. This...
Cronos Group Inc. Announces Second Quarter and First-Half 2019 Results Opened Cronos Device Labs, New Global R&D Center in Israel Appointed Dr. Todd Abraham as Chief Innovation Officer Announced Agreement to Acquire...
This is a copy of the August 4th edition of our weekly Newsletter, which we have been publishing since October 2015. Friends, After months of disappointing developments in the...
Cronos Group Establishes New Growth Opportunity in the United States with Acquisition of Hemp-Based Products Platform TORONTO, Aug. 02, 2019 (GLOBE NEWSWIRE) — Cronos Group Inc. (NASDAQ: CRON) (TSX:...
After a 54.9% gain in Q1, the Canadian Cannabis LP Index gave up about half the gains in Q2. In July, following the surprise termination of Bruce Linton as co-CEO of...
After a 54.9% gain in Q1, the Canadian Cannabis LP Index gave up a lot of ground in Q2, including a 8.4% decline in June to 894.07: The index remains substantially...
After a 54.9% gain in Q1, the Canadian Cannabis LP Index backtracked marginally in April and then fell sharply in May, declining 9.7% to 976.56: The index remains substantially below the all-time...
Cronos Group and MediPharm Labs Enter $30 Million Multi-Year Private Label Cannabis Concentrate Supply Agreement with Potential to Increase to $60 Million Cronos Group and MediPharm Labs Enter Additional...
Cronos Group Inc. Announces First Quarter 2019 Results Cronos Group Closes C$2.4 Billion Strategic Investment from Altria Group Cronos Group Establishes Cronos Device Labs, a State-of-the-Art Vaporizer R&D Initiative...
Cronos Group Opens Cronos Device Labs, New Global R&D Center in Israel Accelerates Efforts to Develop Next-Generation Vaporizer Products Designed Specifically for Cannabinoids TORONTO, May 07, 2019 (GLOBE NEWSWIRE)...
The Public Cannabis Company Revenue Tracker, managed by New Cannabis Ventures, ranks the top revenue producing cannabis stocks that generate industry sales of more than US$2.5 million per quarter. This...
After sinking 43.8% in Q4, the Canadian Cannabis LP Index has rallied 54.9% to begin 2019, including a 9.4% gain in March: The index remains substantially below the all-time closing high of...
This is a copy of the March 31st edition of our weekly Newsletter, which we have been publishing since October 2015. Friends, What a great way to begin 2019!...
Cronos Group Inc. Announces Fourth Quarter 2018 and Full Year 2018 Results Closed C$2.4 Billion Strategic Growth Investment from Altria Group, Inc. Completed first harvest in Peace Naturals expansion...
Investors in the cannabis sector have the ability in the vast majority of cases to invest in companies that trade in both the United States and in Canada. American...
This is a copy of the March 10th edition of our weekly Newsletter, which we have been publishing since October 2015. Friends, This week’s news that FDA Commissioner Scott...
Cronos Group Inc. Closes C$2.4 Billion Strategic Growth Investment from Altria Group, Inc. Four New Directors Join Cronos Group Board Jerry Barbato Appointed Chief Financial Officer of Cronos Group;...
The Public Cannabis Company Revenue Tracker, managed by New Cannabis Ventures, ranks the top revenue producing cannabis stocks that generate industry sales of more than US$2.5 million per quarter. This...
After sinking 43.8% in Q4, the Canadian Cannabis LP Index extended its January rally, rising 4.2% in February to 997.94: The index, up 41.6% to begin 2019, is still down substantially from...
This is a copy of the February 3rd edition of our weekly Newsletter, which we have been publishing since October 2015. Friends, It’s been an exciting month for cannabis...
Cannabis stocks, as measured by the Global Cannabis Stock Index, bounced back sharply from Q4 losses of 44.2%, rallying 44.2% in January to 92.33: The index, which had 43 qualifying...
After sinking 43.8% in Q4, the Canadian Cannabis LP Index rallied sharply to begin the year, rising 36.0% to 958.16: The index ran up into the October legalization beginning in mid-August after the announcement...
NEW YORK–(BUSINESS WIRE)–ICR, a leading strategic communications and advisory firm serving more than 650 private and public company clients, today announced its inaugural dedicated cannabis track at this year’s...
